Syndax Pharmaceuticals, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|
AVTE
Aerovate Therapeutics, Inc. |
$2.60 | $597.48 M | -6.84 | 51 | $0 |
CGEM
Cullinan Oncology, Inc. |
$12.27 | $1.29 B | -7.16 | 85 | $0 |
COGT
Cogent Biosciences, Inc. |
$7.86 | $802.20 M | -3.37 | 164 | $0 |
CYTK
Cytokinetics, Incorporated |
$48.53 | $6.05 B | -9.78 | 423 | $7.53 M |
DICE
DICE Therapeutics, Inc. |
$47.55 | $2.27 B | -21.91 | 71 | $0 |
DYN
Dyne Therapeutics, Inc. |
$23.97 | $3.03 B | -7.77 | 173 | $0 |
EWTX
Edgewise Therapeutics, Inc. |
$29.62 | $1.65 B | -11.47 | 108 | $0 |
INZY
Inozyme Pharma, Inc. |
$2.93 | $286.39 M | -3.43 | 59 | $0 |
KALV
KalVista Pharmaceuticals, Inc. |
$8.76 | $492.76 M | -3.74 | 150 | $0 |
KROS
Keros Therapeutics, Inc. |
$16.71 | $1.76 B | -9.45 | 160 | $151,000 |
KRTX
Karuna Therapeutics, Inc. |
$329.83 | $12.60 B | -28.09 | 339 | $654,000 |
LRMR
Larimar Therapeutics, Inc. |
$3.78 | $611.84 M | -9.99 | 42 | $0 |
MLYS
Mineralys Therapeutics, Inc. |
$12.80 | $652.38 M | -6.03 | 28 | $0 |
MRSN
Mersana Therapeutics, Inc. |
$1.62 | $261.85 M | -1.91 | 123 | $36.86 M |
MRUS
Merus N.V. |
$42.41 | $3.50 B | -19.38 | 172 | $43.95 M |
PCVX
Vaxcyte, Inc. |
$85.91 | $7.72 B | -16.54 | 254 | $0 |
PLRX
Pliant Therapeutics, Inc. |
$13.49 | $672.63 M | -3.9 | 166 | $1.58 M |
REPL
Replimune Group, Inc. |
$12.50 | $485.18 M | -2.44 | 331 | $0 |
RVMD
Revolution Medicines, Inc. |
$44.39 | $6.66 B | -10.51 | 490 | $11.58 M |
STRO
Sutro Biopharma, Inc. |
$1.93 | $303.46 M | -1.97 | 302 | $153.73 M |
VRDN
Viridian Therapeutics, Inc. |
$19.31 | $776.72 M | -2.71 | 94 | $314,000 |